Asthma-Related Health Outcomes Associated with Short-Acting β2-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program

Chloë I. Bloom; Claudia Cabrera; Sofie Arnetorp; Karen Coulton; Cassandra Nan; Ralf J.P. van der Valk; Jennifer K Quint

doi:10.1007/s12325-020-01444-5

July 27, 2020Advances in TherapyOpen Access

Asthma-Related Health Outcomes Associated with Short-Acting β2-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

High SABA inhaler use was frequent across BTS steps and was associated with a significant increase in exacerbations and asthma-related healthcare utilization.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bloom et al. (2020) studied this question.

synapsesocial.com/papers/69e5da6ddb3f836d8f13c50b https://doi.org/10.1007/s12325-020-01444-5

View Full Paper

Ask AI

Bookmark

Share

Asthma-Related Health Outcomes Associated with Short-Acting β2-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program

Ask about this paper

Abstract

Discussion

Cite This Study

Asthma-Related Health Outcomes Associated with Short-Acting β2-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading